Skip to content
Back to INSP

Inspire Medical Systems, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
7
Purchases
0
Sales
7
Purchase value
$0.00
Sale value
$665.95K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Jason P KellySee Remarks
4
Filed Aug 11, 2026Period of report Aug 7, 20260001104659-26-094238
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 7, 2026
Common Stock963$59.55$57.35K18,985Direct
Open on SEC EDGAR
John RondoniSee Remarks
4
Filed May 19, 2026Period of report May 15, 20260001104659-26-063812
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 15, 2026
Common StockF12,641$43.28$114.30K27,165Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.09 to $43.40. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
John RondoniSee Remarks
4
Filed May 15, 2026Period of report May 14, 20260001104659-26-062498
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 14, 2026
Common StockF1700$43.01$30.11K29,806Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.03. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Shawn mcCormickDirector
4Rule 10b5-1 plan disclosed
Filed May 11, 2026Period of report May 8, 20260001104659-26-058634
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 8, 2026
Common Stock696$45.31$31.54K27,712Direct
Open on SEC EDGAR
John RondoniSee Remarks
4Rule 10b5-1 plan disclosed
Filed Jan 12, 2026Period of report Jan 9, 20260001104659-26-002864
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 9, 2026
Common StockF1109$100.00$10.90K13,797Direct
Filing footnotes · 1
  1. F1Includes 140 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated May 21, 2025.
Open on SEC EDGAR
Shawn mcCormickDirector
4Rule 10b5-1 plan disclosed
Filed Dec 4, 2025Period of report Dec 2, 20250001104659-25-118455
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 2, 2025
Common Stock1,200$139.00$166.80K24,846Direct
Open on SEC EDGAR
Shawn mcCormickDirector
4Rule 10b5-1 plan disclosed
Filed Dec 1, 2025Period of report Nov 28, 20250001104659-25-117422
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 28, 2025
Common Stock2,000$127.48$254.96K26,046Direct
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.